256 related articles for article (PubMed ID: 1829371)
1. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
[TBL] [Abstract][Full Text] [Related]
2. The effect of acute ACE inhibition on atrial natriuretic peptide.
Doorenbos CJ; van Brummelen P
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):243S-247S. PubMed ID: 2527537
[TBL] [Abstract][Full Text] [Related]
3. Alpha-adrenergic and angiotensin II pressor sensitivity in hypertensive patients treated with an angiotensin-converting enzyme inhibitor.
Rosendorff C; Patton J; Radford HM; Kalliatakis B
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S105-9. PubMed ID: 1382157
[TBL] [Abstract][Full Text] [Related]
4. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin modulation of sympathetic reflex function in essential hypertension and in the elderly.
Ajayi AA; Reid JL
Int J Clin Pharmacol Res; 1988; 8(5):327-33. PubMed ID: 2852643
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
Uehlinger DE; Ferrier CP; Matthieu R; Reuter K; Gnaedinger MP; Saxenhofer H; Shaw S; Weidmann P
J Hypertens; 1989 Nov; 7(11):901-7. PubMed ID: 2558135
[TBL] [Abstract][Full Text] [Related]
7. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
[TBL] [Abstract][Full Text] [Related]
9. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
Gasic S; Heinz G; Kleinbloesem C; Korn A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
Beretta-Piccoli C; Ferrier C; Weidmann P
Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
[TBL] [Abstract][Full Text] [Related]
12. Effect of angiotensin converting enzyme inhibition on renal response to atrial natriuretic factor in rats.
Wu JN; Huang WC
Proc Natl Sci Counc Repub China B; 1988 Jul; 12(3):186-93. PubMed ID: 2977443
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
[TBL] [Abstract][Full Text] [Related]
14. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and metabolic profile during intervention with urapidil in humans.
Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
Cargill RI; Struthers AD; Lipworth BJ
Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006
[TBL] [Abstract][Full Text] [Related]
17. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study.
Tylicki L; Renke M; Rutkowski P; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
Scand J Urol Nephrol; 2008; 42(4):381-8. PubMed ID: 19230172
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic effects of dual neutral endopeptidase-angiotensin-converting enzyme inhibition versus angiotensin-converting enzyme inhibition in humans.
Massien C; Azizi M; Guyene TT; Vesterqvist O; Mangold B; Ménard J
Clin Pharmacol Ther; 1999 Apr; 65(4):448-59. PubMed ID: 10223783
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II.
Donati L; Bühler FR; Beretta-Piccoli C; Kusch F; Heinen G
Clin Pharmacol Ther; 1992 Jul; 52(1):50-9. PubMed ID: 1385565
[TBL] [Abstract][Full Text] [Related]
20. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, cilazapril, in essential hypertension.
Ajayi AA; Elliott HL; Reid JL
Br J Clin Pharmacol; 1986 Aug; 22(2):167-75. PubMed ID: 3019375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
